Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACHV | OABI | GALT | ||
| Company | Achieve Life Sciences Inc | Omniab Inc | Galectin Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.03 | 1.8400 | 3.47 | ||
| High | 5.30 | 1.9200 | 3.67 | ||
| Low | 5.03 | 1.8400 | 3.45 | ||
| Latest | 5.20 | 1.9000 | 3.54 | ||
| Change | +0.21 | +0.0600 | +0.09 | ||
| % Change | +4.21% | +3.26% | +2.61% | ||
| Volume | 702,400 | 264,400 | 456,900 | ||
| 20-Day Average Volume | 578,575 | 591,350 | 805,485 | ||
| Previous Close | 4.99 | 1.8400 | 3.45 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.63 | 1.9750 | 4.82 | ||
| 20-Day Raw Stochastic | 90.70% | 23.81% | 5.28% | ||
| 20-Day Relative Strength | 61.30 | 52.11 | 35.54 | ||
| Weighted Alpha | +73.43 | -31.67 | +101.11 | ||
| Today's Opinion | 88% Buy | 72% Buy | 8% Sell | ||
| Previous Opinion | 88% Buy | 56% Buy | 16% Sell | ||
| Last Month's Opinion | 96% Buy | 8% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.64% since 12/30/25 | +2.15% since 12/30/25 | -13.24% since 12/30/25 | ||
| Low | 4.69 on 12/31/25 | 1.8000 on 12/31/25 | 3.34 on 01/06/26 | ||
| High | 5.30 on 01/07/26 | 1.9400 on 01/05/26 | 4.35 on 01/02/26 | ||
| 1-Month | |||||
| %Chg | +12.55% since 12/05/25 | -2.56% since 12/05/25 | -38.33% since 12/05/25 | ||
| Low | 4.22 on 12/17/25 | 1.8000 on 12/31/25 | 3.34 on 01/06/26 | ||
| High | 5.30 on 01/07/26 | 2.2200 on 12/12/25 | 7.13 on 12/17/25 | ||
| 3-Month | |||||
| %Chg | +56.63% since 10/07/25 | +15.15% since 10/07/25 | -25.79% since 10/07/25 | ||
| Low | 3.03 on 10/14/25 | 1.3000 on 11/05/25 | 3.34 on 01/06/26 | ||
| High | 5.78 on 10/21/25 | 2.2200 on 12/12/25 | 7.13 on 12/17/25 | ||
| 6-Month | |||||
| %Chg | +151.21% since 07/07/25 | +1.60% since 07/07/25 | +64.65% since 07/07/25 | ||
| Low | 2.06 on 07/08/25 | 1.3000 on 11/05/25 | 2.07 on 07/08/25 | ||
| High | 5.78 on 10/21/25 | 2.2950 on 07/09/25 | 7.13 on 12/17/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 264,573 | 270,635 | 261,116 | ||
| Shares Outstanding, K | 53,234 | 143,955 | 64,473 | ||
| Annual Sales | 0 | 26,390,000 | 0 | ||
| Annual Net Income | -39,830,000 | -62,030,000 | -47,050,000 | ||
| Last Quarter Sales | 0 | 2,240,000 | 0 | ||
| Last Quarter Net Income | -14,440,000 | -16,530,000 | -8,180,000 | ||
| 60-Month Beta | 1.71 | 0.13 | 1.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 11/06/25 | -0.14 on 11/04/25 | -0.13 on 11/14/25 | ||
| Latest Earnings Date | 03/10/26 | 03/17/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||